|
Subsequent Events
|
6 Months Ended | ||
|---|---|---|---|
|
Sep. 30, 2012
|
|||
| Subsequent Events [Abstract] | |||
| Subsequent Events [Text Block] |
On October 3, we announced a multi-year partnership agreement with Life Technologies Corporation for development and commercialization of CollabRx technology and content resources to be used in conjunction with Life Technologies' global cancer diagnostics development and its laboratory developed test services business. The agreement represents a major step forward by our Company in providing laboratories and next-generation sequencing companies with meaningful insights into cancer.
Life Technologies will use our proprietary content and technology to pair the results of broad molecular profiling panels developed by Life Technologies with associated clinically relevant and dynamically updated knowledge on clinical trials, drugs, biologics and other information relevant for cancer treatment planning. This knowledge is supported by CollabRx's large and growing network of over 50 leading clinical practitioners in the United States. While we and our advisors do not provide specific treatment recommendations, this clinically relevant knowledge is a key part of the "context engine" for informing healthcare decision-making.
|